GGCX expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.8517409827723E-12 |
Normal-vs-Stage2 |
1.9642953930088E-11 |
Normal-vs-Stage3 |
5.36015676289026E-13 |
Normal-vs-Stage4 |
1.22760002163602E-09 |
Stage1-vs-Stage2 |
3.497700E-02 |
Stage1-vs-Stage3 |
2.115200E-01 |
Stage1-vs-Stage4 |
4.438200E-01 |
Stage2-vs-Stage3 |
2.938000E-01 |
Stage2-vs-Stage4 |
2.320400E-01 |
Stage3-vs-Stage4 |
7.849200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62536650805123E-12 |
Normal-vs-AfricanAmerican |
1.63324909152607E-12 |
Normal-vs-Asian |
2.193800E-04 |
Caucasian-vs-AfricanAmerican |
1.640100E-02 |
Caucasian-vs-Asian |
7.285200E-01 |
AfricanAmerican-vs-Asian |
5.910200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
9.36151156594178E-12 |
Male-vs-Female |
3.589500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.50679493724238E-11 |
Normal-vs-Age(41-60Yrs) |
1.64657176782157E-12 |
Normal-vs-Age(61-80Yrs) |
2.23154827949656E-14 |
Normal-vs-Age(81-100Yrs) |
7.33720000312132E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.982300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.050000E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.068200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.834600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.882200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.358200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.150080E-02 |
Normal-vs-Grade 2 |
5.44009282066327E-15 |
Normal-vs-Grade 3 |
1.65323310596932E-12 |
Normal-vs-Grade 4 |
3.60109719821367E-11 |
Grade 1-vs-Grade 2 |
1.499240E-01 |
Grade 1-vs-Grade 3 |
4.464500E-02 |
Grade 1-vs-Grade 4 |
1.615710E-02 |
Grade 2-vs-Grade 3 |
7.949400E-01 |
Grade 2-vs-Grade 4 |
2.225800E-01 |
Grade 3-vs-Grade 4 |
3.648400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.7910117833253E-12 |
Normal-vs-ccB subtype |
4.37072600334432E-12 |
ccA subtype-vs-ccB subtype |
4.305600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.94666505137775E-12 |
Normal-vs-N1 |
2.020600E-01 |
N0-vs-N1 |
5.205400E-01 |
|
|